On Oct 29, major Wall Street analysts update their ratings for $Edwards Lifesciences (EW.US)$, with price targets ranging from $70 to $90.
J.P. Morgan analyst Robbie Marcus maintains with a hold rating.
BofA Securities analyst Travis Steed maintains with a hold rating, and maintains the target price at $75.
Citi analyst Joanne Wuensch maintains with a buy rating, and adjusts the target price from $77 to $81.
Barclays analyst Matt Miksic maintains with a buy rating, and maintains the target price at $85.
Wells Fargo analyst Larry Biegelsen maintains with a buy rating, and maintains the target price at $80.
Furthermore, according to the comprehensive report, the opinions of $Edwards Lifesciences (EW.US)$'s main analysts recently are as follows:
Edwards Lifesciences delivered a robust performance, surpassing sales and earnings expectations. The outlook for Q4 and the strategic vision set for 2025 are likely to sustain the stock's upward trajectory.
Following the Q3 report, there is a belief that it will require several more quarters for Edwards Lifesciences to demonstrate to investors that it has established a baseline for the performance of its TAVR franchise.
Expectations were modest prior to the release of the third-quarter results, and the subsequent discussion for the fourth quarter and fiscal year 2025 did not strongly indicate that risks were already priced in. Although the deceleration in fourth-quarter TAVR trends appears to be influenced by certain one-time factors, it remains challenging to definitively argue that TAVR growth will not continue to slow down in fiscal year 2025.
Here are the latest investment ratings and price targets for $Edwards Lifesciences (EW.US)$ from 10 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
